Stay updated with breaking news from Jack Askins. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The U.S. National Institutes of Health (NIH) is conducting a multi-site clinical trial to evaluate Shionogi & Co.’s Xocova COVID-19 antiviral drug to determine its effectiveness in improving care for afflicted individuals.
ZeroHedge - On a long enough timeline, the survival rate for everyone drops to zero
The Food and Drug Administration (FDA) has approved an unprecedented number of emergency use authorizations (EUAs) for drugs, ...
One of the most robustly campaigned and well-known drugs for treating COVID is Paxlovid. Yet the drug's limited ...
Bill Lockwood continues to interview locals that are being affected by vaccine mandates here in Wichita Falls.